26 October 2017 EMA/720706/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: Acetyl salicylic acid / atorvastatin / ramipril

Procedure no.: PSUSA/00010280/201702

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

Sincronia 100 mg/20 mg/10

not available

80938

NEWLINE PHARMA S.L.

ES

not available

80939

NEWLINE PHARMA S.L.

ES

not available

80937

NEWLINE PHARMA S.L.

ES

ES/H/0241/006

BE505022

FERRER INTERNACIONAL,

BE

mg cápsulas duras Sincronia 100 mg/20 mg/5 mg cápsulas duras Sincronia 100 mg/20 mg/2,5 mg cápsulas duras Trinomia 100 mg/40 mg/10 mg harde capsules Trinomia 100 mg/40 mg/5 mg

S.A. ES/H/0241/005

BE505013

harde capsules Trinomia 100 mg/40 mg/2,5

ES/H/0241/004

BE505004

ES/H/0241/006/DC

II-36642

ES/H/0241/005/DC

II-36643

ES/H/0241/004/DC

II-36644

ES/H/0241/005

5704440

ES/H/0241/005

5704432

FERRER INTERNACIONAL, FERRER INTERNACIONAL,

5704457

ES/H/0241/004

5704416

BG PT PT

FERRER INTERNACIONAL, FERRER INTERNACIONAL,

ES/H/0241/004

5704408

FERRER INTERNACIONAL,

PT

S.A. PT

S.A.

2,5 mg cápsulas Trinomia 100 mg + 40 mg +

FERRER INTERNACIONAL,

ES/H/0241/005

2,5 mg cápsulas Trinomia 100 mg + 40 mg +

BG

S.A.

5 mg cápsulas Trinomia 100 mg + 40 mg +

FERRER INTERNACIONAL,

S.A.

5 mg cápsulas Trinomia 100 mg + 40 mg +

BG

S.A.

5 mg cápsulas Trinomia 100 mg + 40 mg +

FERRER INTERNACIONAL,

S.A.

mg твърди капсули Trinomia 100 mg + 40 mg +

BE

S.A.

mg твърди капсули Триномиа 100 mg/40 mg/2,5

FERRER INTERNACIONAL, S.A.

mg твърди капсули Триномиа 100 mg/40 mg/5

BE

S.A.

mg harde capsules Триномиа 100 mg/40 mg/10

FERRER INTERNACIONAL,

PT

S.A. ES/H/0241/004

List of nationally authorised medicinal products EMA/720706/2017

5704424

FERRER INTERNACIONAL,

PT

Page 2/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

2,5 mg cápsulas Trinomia 100 mg + 40 mg +

S.A. ES/H/0241/006

5704721

10 mg cápsulas Trinomia 100 mg + 40 mg +

ES/H/0241/006

5704705

ES/H/0241/006

5704713

ES/H/0241/006

54440

ES/H/0241/004

54438

ES/H/0241/005

54439

ES/H/0241/004

6 154 240 7

ES/H/0241/005

6 451 898 4

ES/H/0241/006

6 272 093 0

ES/H/0241/001

78574

ES/H/0241/002

78575

ES/H/0241/003

78576

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

ES

FERRER INTERNACIONAL,

ES

FERRER INTERNACIONAL,

ES

S.A. ES/H/0241/001

49331

mg kapslar, hårda Trinomia 100 mg/20 mg/5 mg

SE

S.A.

mg cápsulas duras Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

S.A.

cápsulas duras Trinomia 100 mg/20 mg/10

SE

S.A.

mg cápsulas duras Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

gélule Trinomia 100 mg/20 mg/2,5

SE

S.A.

gélule ILTRIA 100 mg/40 mg/10 mg,

FERRER INTERNACIONAL,

S.A.

mg, gélule ILTRIA 100 mg/40 mg/5 mg,

PT

S.A.

hårda kapslar ILTRIA 100 mg/40 mg/2,5

FERRER INTERNACIONAL,

S.A.

mg hårda kapslar Trinomia 100 mg/40 mg/5 mg

PT

S.A.

mg hårda kapslar Trinomia 100 mg/40 mg/2,5

FERRER INTERNACIONAL, S.A.

10 mg cápsulas Trinomia 100 mg/40 mg/10

PT

S.A.

10 mg cápsulas Trinomia 100 mg + 40 mg +

FERRER INTERNACIONAL,

FERRER INTERNACIONAL,

SE

S.A. ES/H/0241/002

kapslar, hårda List of nationally authorised medicinal products EMA/720706/2017

49332

FERRER INTERNACIONAL,

SE

S.A.

Page 3/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

Trinomia 100 mg/20 mg/10

ES/H/0241/003

49333

FERRER INTERNACIONAL,

SE

mg kapslar, hårda Trinomia 100 mg/20 mg/2,5

S.A. ES/H/0241/001/DC

6486/2014/01-05

ES/H/0241/002/DC

6487/2014/01-05

ES/H/0241/003/DC

6488/2014/01-05

mg capsule Trinomia 100 mg/20 mg/5 mg

ES/H/0241/001

5627047

ES/H/0241/001

5627054

ES/H/0241/001

5627062

ES/H/0241/002

5627070

ES/H/0241/002

5627104

ES/H/0241/002

5627112

ES/H/0241/003

5627120

ES/H/0241/003

5627138

ES/H/0241/003

5627146

ES/H/0241/001

II-28096

FERRER INTERNACIONAL,

PT

FERRER INTERNACIONAL,

PT

FERRER INTERNACIONAL,

PT

FERRER INTERNACIONAL,

PT

FERRER INTERNACIONAL,

PT

FERRER INTERNACIONAL,

PT

S.A.

mg твърди капсули Триномиа 100 mg/20 mg/5

PT

S.A.

10 mg cápsulas Триномиа 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

S.A.

10 mg cápsulas Trinomia 100 mg + 20 mg +

PT

S.A.

10 mg cápsulas Trinomia 100 mg + 20 mg +

FERRER INTERNACIONAL,

S.A.

5 mg cápsulas Trinomia 100 mg + 20 mg +

PT

S.A.

5 mg cápsulas Trinomia 100 mg + 20 mg +

FERRER INTERNACIONAL,

S.A.

5 mg cápsulas Trinomia 100 mg + 20 mg +

RO

S.A.

2,5 mg cápsulas Trinomia 100 mg + 20 mg +

FERRER INTERNACIONAL,

S.A.

2,5 mg cápsulas Trinomia 100 mg + 20 mg +

RO

S.A.

2,5 mg cápsulas Trinomia 100 mg + 20 mg +

FERRER INTERNACIONAL, S.A.

mg capsule Trinomia 100 mg + 20 mg +

RO

S.A.

capsule Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL,

FERRER INTERNACIONAL,

BG

S.A. ES/H/0241/002

List of nationally authorised medicinal products EMA/720706/2017

II-28097

FERRER INTERNACIONAL,

BG

Page 4/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

mg твърди капсули Триномиа 100 mg/20 mg/10

S.A. ES/H/0241/003

II-28098

mg твърди капсули Trinomia 100 mg/20 mg/2.5

ES/H/0241/001

PA1744/002/001

ES/H/0241/002

PA1744/002/002

ES/H/0241/003

PA1744/002/003

ES/H/0241/001/E/001

BE469537

ES/H/0241/002/E/001

BE469546

ES/H/0241/003/E/001

BE469555

ES/H/0241/001

BE469537

ES/H/0241/002

BE469546

ES/H/0241/003

BE469555

ES/H/0241/001

BE469537

ES/H/0241/002

BE469546

FERRER INTERNACIONAL,

BE

FERRER INTERNACIONAL,

BE

FERRER INTERNACIONAL,

BE

FERRER INTERNACIONAL,

BE

FERRER INTERNACIONAL,

BE

FERRER INTERNACIONAL,

BE

S.A. ES/H/0241/003

BE469555

mg Hartkapseln Trinomia 100 mg/20 mg/10

BE

S.A.

Hartkapseln Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL,

S.A.

mg Hartkapseln Trinomia 100 mg/20 mg/5 mg

BE

S.A.

mg harde capsules Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

S.A.

harde capsules Trinomia 100 mg/20 mg/10

IE

S.A.

mg harde capsules Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

mg gélules Trinomia 100 mg/20 mg/2,5

IE

S.A.

gélules Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL,

S.A.

mg gélules Trinomia 100 mg/20 mg/5 mg

IE

S.A.

mg hard capsules Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL, S.A.

hard capsules Trinomia 100 mg/20 mg/10

BG

S.A.

mg hard capsules Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

FERRER INTERNACIONAL,

BE

S.A. ES/H/0241/003

mg Hartkapseln List of nationally authorised medicinal products EMA/720706/2017

91938.00.00

FERRER INTERNACIONAL,

DE

S.A.

Page 5/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

Trinomia 100 mg/20 mg/5 mg

ES/H/0241/002

91937.00.00

FERRER INTERNACIONAL,

DE

Hartkapseln Trinomia 100 mg/20 mg/2,5

S.A. ES/H/0241/001

91936.00.00

ES/H/0241/003

136165

ES/H/0241/002

136164

mg Hartkapseln Trinomia 100 mg/20 mg/10

ES/H/0241/001

136163

ES/H/0241/003

043397114

ES/H/0241/002

043397064

ES/H/0241/001

043397013

ES/H/0241/003

043397126

ES/H/0241/003

043397138

ES/H/0241/003

043397140

ES/H/0241/003

043397153

ES/H/0241/002

043397076

ES/H/0241/002

043397088

FERRER INTERNACIONAL,

IT

FERRER INTERNACIONAL,

IT

FERRER INTERNACIONAL,

IT

FERRER INTERNACIONAL,

IT

FERRER INTERNACIONAL,

IT

FERRER INTERNACIONAL,

IT

S.A.

capsule rigide Trinomia 100 mg/20 mg/5 mg

IT

S.A.

capsule rigide Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/5 mg

IT

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL,

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/10

AT

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL,

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/10

AT

S.A.

capsule rigide Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/5 mg

AT

S.A.

mg Hartkapseln Trinomia 100 mg/20 mg/10

FERRER INTERNACIONAL, S.A.

Hartkapseln Trinomia 100 mg/20 mg/2,5

DE

S.A.

mg Hartkapseln Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

FERRER INTERNACIONAL,

IT

S.A. ES/H/0241/002

List of nationally authorised medicinal products EMA/720706/2017

043397090

FERRER INTERNACIONAL,

IT

Page 6/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

capsule rigide Trinomia 100 mg/20 mg/5 mg

S.A. ES/H/0241/002

043397102

capsule rigide Trinomia 100 mg/20 mg/2,5

ES/H/0241/001

043397025

ES/H/0241/001

043397037

ES/H/0241/001

043397049

ES/H/0241/001

043397052

ES/H/0241/001

41/050/15-C

ES/H/0241/002

41/049/15-C

ES/H/0241/003

41/048/15-C

ES/H/0241/003

34009 300 071 8 1

ES/H/0241/001

34009 300 071 6 7

ES/H/0241/002

34009 300 071 6 7

ES/H/0241/001

34009 550 026 3 5

FERRER INTERNACIONAL,

CZ

FERRER INTERNACIONAL,

CZ

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

FR

FERRER INTERNACIONAL,

FR

S.A. ES/H/0241/002

34009 550 026 3 5

gélules Iltria 100 mg/20 mg/10 mg

CZ

S.A.

gélules Iltria 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

gélules Iltria 100 mg/20 mg/2,5 mg

IT

S.A.

gélules Iltria 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

gélules Iltria 100 mg/20 mg/2,5 mg

IT

S.A.

mg tvrdé tobolky Iltria 100 mg/20 mg/10 mg

FERRER INTERNACIONAL,

S.A.

tvrdé tobolky Trinomia 100 mg/20 mg/10

IT

S.A.

mg tvrdé tobolky Trinomia 100 mg/20 mg/5 mg

FERRER INTERNACIONAL,

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/2,5

IT

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL, S.A.

mg capsule rigide Trinomia 100 mg/20 mg/2,5

IT

S.A.

mg capsule rigide Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

FERRER INTERNACIONAL,

FR

S.A. ES/H/0241/003

gélules List of nationally authorised medicinal products EMA/720706/2017

34009 550 026 5 9

FERRER INTERNACIONAL,

FR

S.A.

Page 7/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

TRINOMIA 100 mg / 20 mg /

ES/H/0241/003

32223

FERRER INTERNACIONAL,

FI

10 mg kapseli, kova TRINOMIA 100 mg / 20 mg /

S.A. ES/H/0241/002

32222

ES/H/0241/001

32221

FERRER INTERNACIONAL,

ES/H/0241/001

12478/15/5-10-2016

FERRER-GALENICA S.A.

GR

ES/H/0241/003

12478/15/5-10-2016

FERRER-GALENICA S.A.

GR

ES/H/0241/002

12478/15/5-10-2016

FERRER-GALENICA S.A.

GR

not available

80938

NEWLINE PHARMA S.L.

ES

not available

80939

NEWLINE PHARMA S.L.

ES

not available

80937

NEWLINE PHARMA S.L.

ES

5 mg kapseli, kova TRINOMIA 100 mg / 20 mg /

FI

S.A.

2.5 mg kapseli, kova Trinomia 100 mg/20 mg/2,5

FERRER INTERNACIONAL,

FI

S.A.

mg καψάκια σκληρά Trinomia 100 mg/20 mg/10 mg καψάκια σκληρά Trinomia 100 mg/20 mg/5 mg καψάκια σκληρά Sincronia 100 mg/20 mg/10 mg cápsulas duras Sincronia 100 mg/20 mg/5 mg cápsulas duras Sincronia 100 mg/20 mg/2,5 mg cápsulas duras

List of nationally authorised medicinal products EMA/720706/2017

Page 8/8

Acetyl salicylic acid / atorvastatin / ramipril - European Medicines Agency

Oct 26, 2017 - EMA/720706/2017. Page 3/8. Product Name. (in authorisation country). MRP/DCP Authorisation. Number. National Authorisation. Number. MAH of product in the. Member State. Member State where product is authorised. 2,5 mg cápsulas. S.A.. Trinomia 100 mg + 40 mg +. 10 mg cápsulas. ES/H/0241/006.

131KB Sizes 6 Downloads 186 Views

Recommend Documents

Deoxycholic acid - European Medicines Agency - Europa EU
Nov 30, 2017 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website ...

Mycophenolic acid - European Medicines Agency - Europa EU
Dec 1, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

omega-3-acid-ethyl esters - European Medicines Agency - Europa EU
Sep 29, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop